Showing results (81-90 of 118) with videos related to
Sort By:
Pageof 12
The Journal of Bone and Joint Surgery. British Volume|July 1, 1992
Locked nailing of humeral shaft fractures. Experience in Edinburgh over a two-year periodC M Robinson, K M Bell, C M Court-Brown, et al.Bioorganic & Medicinal Chemistry Letters|November 15, 2000
N-Cyclohexylethyl-N-noroxymorphindole: a mu-opioid preferring analogue of naltrindoleA Coop, A E Jacobson, M D Aceto, et al.The Journal of Peptide Research : Official Journal of the American Peptide Society|October 13, 2005
Design of high affinity cyclic pentapeptide ligands for kappa-opioid receptorsM J Przydzial, I D Pogozheva, J C Ho, et al.Brain Research|September 14, 1999
The effects of the phyllolitorin analogue [desTrp(3), Leu(8)]phyllolitorin on scratching induced by bombesin and related peptides in ratsM D Johnson, M Ko, K S Choo, et al.The Journal of Peptide Research : Official Journal of the American Peptide Society|March 25, 2005
Roles of residues 3 and 4 in cyclic tetrapeptide ligand recognition by the kappa-opioid receptorM J Przydzial, I D Pogozheva, K E Bosse, et al.The Journal of Pharmacology and Experimental Therapeutics|August 17, 2000
Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamineJ H Broadbear, T L Sumpter, T F Burke, et al.Psychiatry Research|December 1, 1990
Effects of chronic imipramine treatment on subclasses of platelet 3H-imipramine binding sites and plasma cortisolE M DeMet, A Chicz-DeMet, K M Bell, et al.Psychiatry Research|December 1, 1990
Seasonal changes in cyanoimipramine specific platelet 3H-imipramine binding in depressionE M DeMet, K M Bell, C Reist, et al.International Journal of Cancer|October 23, 1997
Vascular response of tumour and normal tissues to endothelin-1 following antagonism of ET(A) and ET(B) receptors in anaesthetised ratsK M Bell, V E Prise, D J Chaplin, et al.The Journal of Pharmacology and Experimental Therapeutics|November 18, 2000
Tetrapeptide derivatives of [D-Pen(2),D-Pen(5)]-enkephalin (DPDPE) lacking an N-terminal tyrosine residue are agonists at the mu-opioid receptorI J McFadyen, K Sobczyk-Kojiro, M J Schaefer, et al.Pageof 12